Feeding dendritic cells with tumor antigens: self-service buffet or à la carte? (Q33986125)

30 July 2017

1 reference

title

Feeding dendritic cells with tumor antigens: self-service buffet or à la carte? (English)

1 reference

30 July 2017

1 reference

Melero I

1

1 reference

30 July 2017

Vile RG

series ordinal

2

1 reference

30 July 2017

Colombo MP

series ordinal

3

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

7

1 reference

30 July 2017

issue

14

1 reference

30 July 2017

page(s)

1167-1170

1 reference

Dendritic cell vaccines for cancer immunotherapy

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Immunotherapy of cancer with dendritic cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Activation of human dendritic cells through CD40 cross-linking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Heat shock protein--peptide complexes as immunotherapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

The induction of tolerance by dendritic cells that have captured apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Apoptosis or necrosis for tumor immunotherapy: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

An innate sense of danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Interleukin-12: a cytokine at the interface of inflammation and immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Antitumor activities of IL-12 and mechanisms of action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

IL-12 Acts Directly on DC to Promote Nuclear Localization of NF-κB and Primes DC for IL-12 Production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301234

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301234

1 reference

30 July 2017

1 reference